| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | ambrisentan | FAERS: 10 | US FAERS | |
| 2 | Dimethyl Fumarate | FAERS: 5 | US FAERS | |
| 3 | apremilast | FAERS: 4 | US FAERS | |
| 4 | Teriparatide | FAERS: 2 | US FAERS | |
| 5 | Thyroxine | FAERS: 2 | US FAERS | |
| 6 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 1 | US FAERS | |
| 7 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 8 | Alendronate | FAERS: 1 | US FAERS | |
| 9 | Amoxicillin | FAERS: 1 | US FAERS | |
| 10 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 11 | Aspirin | FAERS: 1 | US FAERS | |
| 12 | Carbidopa, levodopa, and entacapone | FAERS: 1 | US FAERS | |
| 13 | Cefdinir | FAERS: 1 | US FAERS | |
| 14 | Esomeprazole | FAERS: 1 | US FAERS | |
| 15 | Ezetimibe | FAERS: 1 | US FAERS | |
| 16 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 17 | Lenalidomide | FAERS: 1 | US FAERS | |
| 18 | Leuprolide | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 19 | Mesalamine | FAERS: 1 | US FAERS | |
| 20 | NuvaRing | FAERS: 1 | US FAERS | |
| 21 | Ospemifene | FAERS: 1 | US FAERS | |
| 22 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 23 | Sofosbuvir | FAERS: 1 | US FAERS | |
| 24 | Tazobactam | FAERS: 1 | US FAERS | |
| 25 | Thyroxine | FAERS: 1 | US FAERS | |
| 26 | Ticlopidine | FAERS: 1 | US FAERS | |
| 27 | Valproic Acid | FAERS: 1 | US FAERS | |
| 28 | idelalisib | FAERS: 1 | US FAERS | |
| 29 | pomalidomide | FAERS: 1 | US FAERS | |
| 30 | sumatriptan-naproxen | FAERS: 1 | US FAERS | |
| 31 | Etodolac | OFFSIDES | ||
| 32 | Pamidronate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.